| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |